Natrecor

Active Ingredient(s): Nesiritide, BNP
FDA Approved: * August 10, 2001
Pharm Company: * SCIOS
Category: Blood Vessels

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Natrecor Overview

Nesiritide (Natrecor) is the recombinant form of the 32 amino acid human B-type natriuretic peptide, which is normally produced by the ventricular myocardium. Nesiritide works to facilitate cardiovascular fluid homeostasis through counterregulation of the renin–angiotensin–aldosterone system, stimulating cyclic guanosine monophosphate, leading to smooth muscle cell relaxation. Nesiritide was believed initially to be beneficial for acute decompensated congestive heart failure. It r...

Read more Natrecor Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Nesiritide

Recent Natrecor Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Nesiritide, BNP
  • For Solution: 1.5mg/vial
  • Injection: 1.5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Natrecor: (1 result)

Sorted by National Drug Code
  • 65847-205 Natrecor 1.5 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Scios LLC

Other drugs which contain Nesiritide, BNP or a similar ingredient: (1 result)

Related Natrecor Topics:

Natrecor
CHF...






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 July 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA